Viewing Study NCT00134069


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2026-04-08 @ 12:53 PM
Study NCT ID: NCT00134069
Status: COMPLETED
Last Update Posted: 2014-04-16
First Post: 2005-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Colon Cancer View
None Recurrent Rectal Cancer View
None Stage III Colon Cancer View
None Stage III Rectal Cancer View
None Stage IV Colon Cancer View
None Stage IV Rectal Cancer View
Keywords: